Ars Pharmaceuticals Inc (SPRY)
Operating Income Growth
-264.44%
TTM · Period ending:
SPRY Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-264.44%period ending
Latest reported-264.44%period ending
SPRY TTM Operating Income YoY % (38.70% → -264.44%)
Year-over-year change
High-resolution chart · PNG
SPRY operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -264.4417% | |
| -647.8055% | |
| -5,720.5644% | |
| -50.0446% | |
| -4.5932% | |
| 56.3412% | |
| 95.4339% | |
| 16.8154% | |
| 7.5795% | |
| -31.5489% | |
| -90.1115% | |
| -190.5528% | |
| -155.5745% | |
| -113.1181% | |
| -82.564% | |
| 9.2774% | |
| 15.5445% | |
| 24.3807% | |
| 38.7025% |